Compare · treatment

Proton therapy
vs IMRT.

Both deliver radiation to a tumour. IMRT uses photons (X-rays) and is the standard high-precision photon radiotherapy. Proton therapy uses accelerated protons that deposit most of their energy at a defined depth (Bragg peak), sparing healthy tissue distal to the tumour.

Verdict

The bottom line.

Proton therapy for: paediatric cancers, prostate, head & neck, base-of-skull tumours, selected lung — anywhere reducing collateral dose to healthy tissue is critical. IMRT for: most adult solid tumours where dosimetric difference is marginal and cost-effectiveness favours IMRT.

Side-by-side

Proton therapy vs IMRT, by the numbers.

Proton therapy
IMRT
Beam type
Accelerated protons
Photons (X-rays)
Dose depositionProton therapy
Bragg peak (defined depth, then stops)
Continuous along beam path
Healthy tissue sparedProton therapy
Distal to tumour
Both proximal and distal exposed
Best for paediatricsProton therapy
Strongly preferred
Acceptable alternative
Best for prostate cancerProton therapy
Strongly preferred (rectum sparing)
Acceptable alternative
Best for base-of-skull tumoursProton therapy
Strongly preferred
Difficult due to optic structures
Best for diffuse lymphomatie
Marginal benefit
Standard of care
Course cost (China)IMRT
$40,000–$120,000
$8,000–$25,000
Course cost (US)IMRT
$150,000–$250,000
$30,000–$80,000
Centres in ChinaIMRT
8 clinical (Shanghai, Wuwei, Hefei...)
All major Class A cancer centres
Course durationtie
4–8 weeks daily fractions
4–8 weeks daily fractions
Insurance coverageIMRT
Often requires pre-auth
Standard coverage

Verdict markers (↑) indicate where the listed option has a clear advantage based on aggregate evidence and pricing as of 2024–2025. Individual cases vary — request a personalized assessment for your specific situation.

FAQ

Proton therapy vs IMRT, answered.

Is proton therapy better than IMRT?
Dosimetrically — yes, in defined indications where reducing collateral dose to healthy tissue is critical (paediatrics, prostate, base of skull, head & neck). Clinically — the survival benefit is well-established for paediatric cancers but is modest or unproven for many adult indications. IMRT remains standard of care for most diffuse adult solid tumours.
Why is proton therapy more expensive?
The synchrotron / cyclotron accelerator infrastructure costs $100M+ to build and is staffed by specialised physicists and engineers. Course pricing in China ($40,000–$120,000) reflects amortisation of that infrastructure across patient volume — still ~⅓ of US pricing.
When should I choose proton over IMRT?
Proton recommended: paediatric cancer (under 18), tumours adjacent to optic structures or critical neurological tissue, prostate cancer (when rectal sparing matters), chordoma / chondrosarcoma. IMRT recommended: most adult diffuse solid tumours, breast cancer, lung cancer when not adjacent to critical structures, and where cost-effectiveness analysis favours IMRT.

Need a personalized
recommendation?

The verdict above is general. Send your case and we’ll return a personalized recommendation — destination, hospital, treatment plan and itemized quote — in 5 business days.